However, lowering the stringency threshold, by allowing some deviations in the marker expression profiles, identified an HLA-DR+ EM CD4+ T cell subset in the blood samples that displayed a phenotype similar to one of the most discriminatory cell types in inflamed-IBD biopsies (Figure 5B). The gene discussed is CD4; the disease is inflammatory bowel disease.